This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

Determinants of outpatient antibiotic consumption in Europe: bacterial resistance and drug prescribers

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Giuliano Masiero () (Department of Economics and Technology Management, University of Bergamo, Italy; Department of Economics, University of Lugano, Switzerland.)
Massimo Filippini (Department of Economics, University of Lugano; Swiss Federal Institute of Technology, Zurich, Switzerland.)
Matus Ferech (Laboratory of Microbiology, University of Antwerp, Belgium; Enterprise and Industry DG, Pharmaceuticals Unit, European Commission, Brussels.)
Herman Goossens (Laboratory of Microbiology, University of Antwerp, Belgium; Laboratory of Microbiology, Leiden University Medical center, Leiden, The Netherlands.)

Additional information is available for the following registered author(s):

Abstract

This paper investigates socioeconomic determinants of outpatient antibiotic consumption in Europe. Comparable data on antibiotic use measured in the defined daily doses per 1000 inhabitants (DID) are currently provided by the ESAC project. Results from applied econometric estimations for panel data reveal a link between antibiotic use and the per capita income, the demographic structure of the population, the level of education and cultural aspects. Supply-side factors, such as the density of providers and their remuneration methods, are also considered. We provide the first estimate of the impact of bacterial resistance on consumption when the e?ect of other determinants is simultaneously taken into account.

Download Info
To download:

If you experience problems downloading a file, check if you have the proper application to view it first. Information about this may be contained in the File-Format links below. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://doc.rero.ch/lm.php?url=1000,42,6,20070702170710-ER/wp0702.pdf
File Format: application/pdf
File Function:
Download Restriction: no

Publisher Info
Paper provided by Biblioteca universitaria di Lugano (University Library of Lugano) in its series Quaderni della facoltà di Scienze economiche dell'Università di Lugano with number 0702.

Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF
Length: 28 pages
Date of creation: Jun 2007
Date of revision:
Handle: RePEc:lug:wpaper:0702

Contact details of provider:
Web page: http://www.library.lu.usi.ch

For technical questions regarding this item, or to correct its listing, contact: (Alessio Tutino).

Related research
Keywords: Antibiotic use; Cross-country variations; Bacterial resistance; Supply-induced demand;

Find related papers by JEL classification:
I0 - Health, Education, and Welfare - - General
C3 - Mathematical and Quantitative Methods - - Multiple or Simultaneous Equation Models; Multiple Variables

This paper has been announced in the following NEP Reports:

References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
  1. Di Matteo, Livio, 2005. "The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time," Health Policy, Elsevier, vol. 71(1), pages 23-42, January. [Downloadable!] (restricted)
  2. Filippini, Massimo & Masiero, Giuliano & Moschetti, Karine, 2006. "Socioeconomic determinants of regional differences in outpatient antibiotic consumption: Evidence from Switzerland," Health Policy, Elsevier, vol. 78(1), pages 77-92, August. [Downloadable!] (restricted)
  3. Adriana Lleras-Muney & Frank R. Lichtenberg, 2002. "The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs," NBER Working Papers 9185, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
  4. Baye, Michael R & Maness, Robert & Wiggins, Steven N, 1997. "Demand Systems and the True Subindex of the Cost of Living for Pharmaceuticals," Applied Economics, Taylor and Francis Journals, vol. 29(9), pages 1179-89, September. [Downloadable!] (restricted)
    Other versions:
  5. Hunt-McCool, Janet & Kiker, B F & Ng, Ying Chu, 1994. "Estimates of the Demand for Medical Care under Different Functional Forms," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 9(2), pages 201-18, April-Jun. [Downloadable!] (restricted)
  6. Laxminarayan, Ramanan & Weitzman, Martin L., 2002. "On the implications of endogenous resistance to medications," Journal of Health Economics, Elsevier, vol. 21(4), pages 709-718, July. [Downloadable!] (restricted)
  7. Elamin H. Elbasha, 2003. "Deadweight loss of bacterial resistance due to overtreatment," Health Economics, John Wiley & Sons, Ltd., vol. 12(2), pages 125-138. [Downloadable!]
  8. Rudholm, Niklas, 2002. "Economic implications of antibiotic resistance in a global economy," Journal of Health Economics, Elsevier, vol. 21(6), pages 1071-1083, November. [Downloadable!] (restricted)
  9. Rizzo, John A, 1999. "Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs," Journal of Law & Economics, University of Chicago Press, vol. 42(1), pages 89-116, April.
Full references

Statistics
Access and download statistics

Did you know? RePEc stands for Research Papers in Economics.

This page was last updated on 2009-11-16.


This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.